Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation TCT 2025

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 28, 2025

Presentation TCT 2025

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

Presenter: Ritu Yadav

October 27, 2025

Presentation TCT 2025

TCT 94: Impact of Sodium-Glucose Cotransporter-2 Inhibitors On Contrast-Induced Acute Kidney Injury in Diabetic Patients Treated with Percutaneous Coronary Intervention

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 26, 2025

Presentation TCT 2025

TCT 752: Sodium-Glucose Co-Transporter 2 Inhibitors use and Outcomes in Heart Failure patients undergoing Mitra Clip: A Real World Propensity Matched Analysis

Presenter: Aymen Ahmed

October 25, 2025

Presentation NY Valves 2025

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT Abstracts 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Sodium Free Chloride Supplementation in Stable Heart Failure Patients: A Randomized Controlled Trial

Presenter: Juan Ivey-Miranda

February 11, 2025

Presentation THT 2025

Effects of Sodium Chloride and Volume Supplementation During the Treatment of Acute Heart Failure: A Prospective, Randomized, Mechanistic Study

Presenter: Jan Biegus

February 11, 2025

Presentation TCT 2024

TCT 819: Impact of Sodium-Glucose Co-Transporter Inhibitors on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

Presenter: Mohammad Akkawi

October 29, 2024

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

TCT 187: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

Presenter: Tayyab Shah

October 27, 2024

Presentation THT 2024

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance

Presenter: Jeffrey Testani

March 06, 2024

Presentation ESC 2023

The Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial

Presenter: Jozine M. ter Maaten

August 28, 2023

Presentation TCT 2022

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

Presenter: Rayan Yousefzai

September 18, 2022

Presentation ACC 2022

SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure

Presenter: Justin Ezekowitz

April 04, 2022

Presentation TCT 2019

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

Presenter: Jeffrey Testani

September 28, 2019

Advertisement

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

TCT 94: Impact of Sodium-Glucose Cotransporter-2 Inhibitors On Contrast-Induced Acute Kidney Injury in Diabetic Patients Treated with Percutaneous Coronary Intervention

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

TCT 752: Sodium-Glucose Co-Transporter 2 Inhibitors use and Outcomes in Heart Failure patients undergoing Mitra Clip: A Real World Propensity Matched Analysis

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Sodium Free Chloride Supplementation in Stable Heart Failure Patients: A Randomized Controlled Trial

Effects of Sodium Chloride and Volume Supplementation During the Treatment of Acute Heart Failure: A Prospective, Randomized, Mechanistic Study

TCT 819: Impact of Sodium-Glucose Co-Transporter Inhibitors on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 187: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance

The Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content